Maryam Aftab | Health & Medicine | FRP Academic Excellence Award

Published on by Fiber-Reinforced Polymer

Dr. Maryam Aftab | Health & Medicine | FRP Academic Excellence Award

Assistant Professor | Rawalpindi Women University | Pakistan

Maryam Aftab’s research focuses on the design, synthesis, and biomedical applications of inorganic-based nanomaterials, with particular emphasis on wound healing and regenerative medicine. Her work explores how nanostructured materials enhance antimicrobial activity, tissue regeneration, and controlled drug delivery to improve healing outcomes. She critically examines current challenges, including biocompatibility, toxicity, and clinical translation, while identifying future opportunities for advanced therapeutic solutions. Through interdisciplinary approaches combining materials science and biomedical engineering, her research contributes to the development of innovative, efficient, and scalable nanomaterial-based strategies for next-generation wound care and healthcare applications.

Citation Metrics (Scopus)

40
30
20
10
0

Citations
31

Documents
9

h-index
3


View Scopus Author Profile

Featured Publications

Gilles Pagès | Health & Medicine | Research Excellence Award

Published on by Fiber-Reinforced Polymer

Dr. Gilles Pagès | Health & Medicine | Research Excellence Award

Director of Research Exceptional Class | INSERM | France

Dr. Gilles Pagès is an internationally recognized scientist whose research has made substantial contributions to molecular and cellular biology, particularly in the fields of autophagy, intracellular signaling pathways, and mechanisms of disease progression. His work has played a pivotal role in understanding the regulation of mitogen-activated protein kinases (MAPKs), specifically p42MAPK and p44MAPK, which are fundamental to cell proliferation, differentiation, and survival processes. He has significantly advanced knowledge on the nuclear translocation of MAPKs in response to growth factors, thereby elucidating essential regulatory steps in fibroblast signaling. Additionally, his groundbreaking study demonstrating defective thymocyte maturation in ERK1 knockout models has deepened scientific understanding of immune system development, highlighting critical links between signal transduction and immune function. Dr. Pagès has also contributed to receptor biology, including research on thrombin receptor function related to calcium mobilization. He is recognized globally for co-authoring the comprehensive consensus resource “Guidelines for the use and interpretation of assays for monitoring autophagy,” which remains a cornerstone reference widely used to standardize experimental approaches and ensure accurate interpretation in autophagy research across disciplines. With publications in top-tier journals such as Science and PNAS and exceptional citation impact reflecting widespread influence, his work supports advancement in disease modeling, oncology, and therapeutic innovations. Dr. Pagès continues to drive scientific progress through rigorous experimental research, impactful knowledge dissemination, and leadership in collaborative initiatives that strengthen the global research community.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., … Pagès, G. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1–382.

Pagès, G., Lenormand, P., L’Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proceedings of the National Academy of Sciences, 90(18), 8319–8323.

Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., … Pouysségur, J. (1999). Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science, 286(5443), 1374–1377.

Lenormand, P., Sardet, C., Pagès, G., L’Allemain, G., Brunet, A., & Pouysségur, J. (1993). Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. The Journal of Cell Biology, 122(5), 1079–1088.

Rasmussen, U. B., Vouret-Craviari, V., Jallat, S., Schlesinger, Y., Pagès, G., … G. G. (1991). cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca2+ mobilization. FEBS Letters, 288(1–2), 123–128.

 

Eman Abdeall | Health & Medicine | Best Researcher Award

Published on by Fiber-Reinforced Polymer

Prof. Eman Abdeall | Health & Medicine | Best Researcher Award

Head of Department | Beni-Suef Univeristy | Egypt

Prof. Eman K. A. Abdelall is an accomplished researcher specializing in pharmaceutical organic chemistry with a focus on drug synthesis, molecular design, and structure-activity relationship studies. Her extensive research portfolio demonstrates a strong commitment to the discovery and development of bioactive compounds targeting critical human diseases. She has made significant advancements in the design and synthesis of novel molecules with anti-inflammatory, anticancer, and antiviral properties, employing a multidisciplinary approach that integrates organic synthesis, computational modeling, and biological evaluation. Her recent studies include the development of quinazolinone-based compounds as dual STAT-3 and c-Src inhibitors, the design of antipyrine-celecoxib hybrid analogues with dual COX-2 and SARS-CoV-2 Mpro inhibitory activities, and the synthesis of new pyrazoles with selective anti-inflammatory potential. Prof. Abdelall’s work, published in high-impact journals such as Bioorganic Chemistry, Bioorganic and Medicinal Chemistry Letters, and Drug Development Research, reflects her expertise in rational drug design and her ability to translate molecular innovations into pharmacologically relevant candidates. With 46 peer-reviewed publications, over 1,045 citations, and an h-index of 20, her research demonstrates both quality and global impact. Her findings contribute to understanding molecular mechanisms underlying inflammation, cancer proliferation, and viral replication, offering new therapeutic strategies with enhanced efficacy and safety. Through her sustained publication record, interdisciplinary research, and consistent scientific innovation, Prof. Abdelall has established herself as a leading contributor in pharmaceutical chemistry, advancing the field of rational drug design and synthesis with high translational value for modern medicine.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  • Abdelall, E. K. A., Lamie, P. F., Fadaly, W. A. A., & Abdelgawad, Y. Y. M. (2025). Development of novel quinazolinone-based compounds with anti-proliferative activity as dual STAT-3 and c-Src inhibitors: Design, synthesis and molecular dynamic studies. Bioorganic Chemistry, 163, 108753.

  • Abdelall, E. K. A., Elshemy, H. A. H., Labib, M. B., Philoppes, J. N., Ali, F. E. M., & Ahmed, A. K. M. (2025). Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities. Bioorganic Chemistry, 160, (Article number not specified).

  • Abdelall, E. K. A., EL-Nahass, E. S., Abdellatif, K. R. A., Abdel-Rahman, H. M. (2021). Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4-(methylsulfonyl)phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors. RSC Advances, 11, 27659.